LifeTech Scientific Corporation
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HKSE · 2675.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Shenzhen Edge Medical Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 58.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Shenzhen Edge Medical Co Ltd’s next earnings report is currently expected on Mar 29, 2027, with estimated earnings per share of HK$0.33. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen Edge Medical Co Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS through a single small incision or natural orifice; Edge Cloud Telesurgery System; and Edge Bronchoscope Robot. The company also develops and manufactures instruments for Edge Multi-Port Endoscopic Surgical Robot and Single-Port Endoscopic Surgical Robot includes bipolar grasping forceps, bipolar separation forceps, needle holder forceps, monopolar scissors, monopolar electric hooks and other surgical tools. In addition, the company develops an non-invasive surgery by developing natural orifice surgical robots. It serves hospitals. The company sells its products through distributors. The company was formerly known as Shenzhen Jingfeng Medical Technology Co., Ltd. The company was incorporated in 2017 and is based in Shenzhen, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HK$18.64-HK$0.58 (-3.02%)
Zylox-Tonbridge Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.43% below the high.
HK$30.00+HK$0.36 (+1.21%)
Shanghai Kindly Medical Instruments Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.54% below the high.
HK$13.15-HK$1.10 (-7.72%)
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.59% below the high.
HK$6.22+HK$0.07 (+1.14%)
Medcaptain Medical Technology Co. Ltd. Class H’s quoted price sits in the lower half of its reported 52-week range, 42.94% below the high.
HK$6.70-HK$0.01 (-0.07%)
MicroTech Medical (Hangzhou) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.08% below the high.
HK$3.77-HK$0.15 (-3.83%)
Peijia Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 48.85% below the high.
HK$53.20+HK$0.25 (+0.47%)
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.